Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immuneering Corp Cl A
(NQ:
IMRX
)
1.450
-0.110 (-7.05%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
252,267
Open
1.590
Bid (Size)
1.400 (29)
Ask (Size)
1.460 (1)
Prev. Close
1.560
Today's Range
1.400 - 1.590
52wk Range
1.380 - 11.92
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
IMRX Stock Earnings: Immuneering Misses EPS for Q1 2024
May 07, 2024
IMRX stock results show that Immuneering missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
May 07, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Performance
YTD
-80.19%
-80.19%
1 Month
-33.79%
-33.79%
3 Month
-76.19%
-76.19%
6 Month
-72.12%
-72.12%
1 Year
-79.86%
-79.86%
More News
Read More
Immuneering Recognizes Melanoma Awareness Month
May 06, 2024
From
Immuneering Corporation
Via
GlobeNewswire
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
April 09, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations
March 27, 2024
From
Immuneering Corporation
Via
GlobeNewswire
3 Stocks Insiders Are Buying That Analysts Love
March 26, 2024
Via
MarketBeat
March Madness Market Movers: INBS, NCMI, CIFR, IMRX, STI
March 19, 2024
Via
AB Newswire
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 18, 2024
Via
Benzinga
Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data
March 15, 2024
Via
Benzinga
Dow Falls Over 200 Points; Adobe Shares Plunge
March 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 15, 2024
Via
Benzinga
Crude Oil Edges Lower; US Consumer Sentiment Falls In March
March 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via
Benzinga
What's Going On With Cancer-Focused Immuneering Stock On Thursday?
March 14, 2024
Via
Benzinga
US Stocks Higher; Producer Prices Rise 0.6% In February
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Via
Benzinga
Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors
March 14, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors
March 12, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Doses First Patient in Phase 2a Clinical Trial of IMM-1-104 in RAS-mutant Solid Tumors
March 11, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth
March 06, 2024
Via
FinancialNewsMedia
Immuneering to Present Preclinical Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2024
March 05, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Participate in the Cowen 44th Annual Health Care Conference
March 04, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.